NVWM LLC’s Definium Therapeutics DFTX Stock Holding History

NVWM LLC’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.8K	Hold	416	–	–	﹤0.01%	346
2026 Q2	$19.6K	Hold	416	–	–	﹤0.01%	277
2026 Q1	$7.86K	Hold	416	–	–	﹤0.01%	319
2025 Q4	$5.57K	Hold	416	–	–	﹤0.01%	349
2025 Q3	$4.9K	Hold	416	–	–	﹤0.01%	349
2025 Q2	$2.7K	Hold	416	–	–	﹤0.01%	384
2025 Q1	$2.43K	Hold	416	–	–	﹤0.01%	369
2024 Q4	$2.9K	Hold	416	–	–	﹤0.01%	347
2024 Q3	$2.37K	Hold	416	–	–	﹤0.01%	361
2024 Q2	$3K	Hold	416	–	–	﹤0.01%	341
2024 Q1	$3.91K	Hold	416	–	–	﹤0.01%	325
2023 Q4	$1.52K	Buy	+416	New	+$1.25K	﹤0.01%	369

Other funds holding DFTX

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return

Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

NVWM LLC's DFTX Position: Q3 2026 in Review

NVWM LLC held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 416 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

NVWM LLC first reported a position in DFTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $19.6K in Q2 2026. 46 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

NVWM LLC held 416 shares of Definium Therapeutics worth $15.8K as of Q3 2026.
NVWM LLC left its Definium Therapeutics share count unchanged in Q3 2026.
Definium Therapeutics made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #346 holding.
NVWM LLC first reported a position in Definium Therapeutics in Q4 2023 and has held it in 12 quarters since.
NVWM LLC's Definium Therapeutics position peaked at $19.6K in Q2 2026.
46 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.